BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,890 | -3.4% | 267 | -4.0% | 0.00% | – |
| Q2 2023 | $1,957 | -16.2% | 278 | -0.7% | 0.00% | – |
| Q1 2023 | $2,335 | -23.5% | 280 | +5.3% | 0.00% | – |
| Q4 2022 | $3,054 | +1.8% | 266 | +2.7% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 259 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 259 | -85.3% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | +20.8% | 1,759 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $24,000 | -4.0% | 1,759 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $25,000 | -10.7% | 1,759 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | +55.6% | 1,759 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $18,000 | +63.6% | 1,759 | +17.3% | 0.00% | 0.0% |
| Q4 2020 | $11,000 | +1000.0% | 1,500 | +200.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |